0
0 (0%)
Ladrx Corp [CYTR]
Source:
Company Overview
LadRx Corporation is a bio pharmaceutical research and development company specializing in oncology. The Company’s focus is on the discovery, research and clinical development of novel anti-cancer drug candidates that employ novel technologies that target chemotherapeutic drugs to solid tumors and reduce off-target toxicities.
| Country | United States |
| Headquarters | los angeles, california |
| Phone Number | (310) 826-5648 |
| Industry | manufacturing |
| CEO | Stephen Snowdy, Ph.D. |
| Website | www.ladrxcorp.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-3.6 |
| Net Income | $-1.6 |
| Net Cash | $-1.3 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -101% |
| Profit as % of Stockholder Equity | 112% |
Management Effectiveness
| Return on Equity | 112% |
| Return on Assets | -189.4% |
| Turnover Ratio | |
| EBITA | $-3.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $0.8 |
| Total Liabilities | $2.3 |
| Operating Cash Flow | $-1.3 |
| Investing Cash Flow | |
| Financing Cash Flow | $0 |
